Related references
Note: Only part of the references are listed.C3 Glomerulopathy: Clinicopathologic Features and Predictors of Outcome
Nicholas R. Medjeral-Thomas et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Complement factor H related hybrid protein deregulates complement in dense deposit disease
Qian Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
A novel CFHR5 mutation associated with C3 glomerulonephritis in a Turkish girl
Nesrin Besbas et al.
JOURNAL OF NEPHROLOGY (2014)
Clinical Findings, Pathology, and Outcomes of C3GN after Kidney Transplantation
Ladan Zand et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Characterization of a Factor H Mutation That Perturbs the Alternative Pathway of Complement in a Family with Membranoproliferative GN
Edwin K. S. Wong et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
A novel CFHR5 fusion protein causes C3 glomerulopathy in a family without Cypriot ancestry
Nicholas Medjeral-Thomas et al.
KIDNEY INTERNATIONAL (2014)
Toward a working definition of C3 glomerulopathy by immunofluorescence
Jean Hou et al.
KIDNEY INTERNATIONAL (2014)
Eculizumab in dense-deposit disease after renal transplantation
Ana Sanchez-Moreno et al.
PEDIATRIC NEPHROLOGY (2014)
Eculizumab therapy in a patient with dense-deposit disease associated with partial lipodystropy
Ozan Ozkaya et al.
PEDIATRIC NEPHROLOGY (2014)
Rituximab fails where eculizumab restores renal function in C3nef-related DDD
Caroline Rousset-Rouviere et al.
PEDIATRIC NEPHROLOGY (2014)
C3 glomerulopathy-associated CFHR1 mutation alters FHR oligomerization and complement regulation
Agustin Tortajada et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
DGKE Variants Cause a Glomerular Microangiopathy That Mimics Membranoproliferative GN
Fatih Ozaltin et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Soluble CR1 Therapy Improves Complement Regulation in C3 Glomerulopathy
Yuzhou Zhang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
C3 glomerulopathy: consensus report
Matthew C. Pickering et al.
KIDNEY INTERNATIONAL (2013)
Eculizumab and recurrent C3 glomerulonephritis
Sevgi Gurkan et al.
PEDIATRIC NEPHROLOGY (2013)
Evolution of immunoglobulin deposition in C3-dominant membranoproliferative glomerulopathy
Eric Kerns et al.
PEDIATRIC NEPHROLOGY (2013)
Dimerization of complement factor H-related proteins modulates complement activation in vivo
Elena Goicoechea de Jorge et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Dense Deposit Disease and C3 Glomerulopathy
Thomas D. Barbour et al.
SEMINARS IN NEPHROLOGY (2013)
Recurrent Dense Deposit Disease After Renal Transplantation: An Emerging Role for Complementary Therapies
J. A. McCaughan et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Eculizumab for Dense Deposit Disease and C3 Glomerulonephritis
Andrew S. Bomback et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Pathology after Eculizumab in Dense Deposit Disease and C3 GN
Leal C. Herlitz et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
A Hybrid CFHR3-1 Gene Causes Familial C3 Glomerulopathy
Talat H. Malik et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Eculizumab for the Treatment of Dense-Deposit Disease
Marina Vivarelli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Eculizumab in a Patient with Dense-Deposit Disease
Erica Daina et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Eculizumab and Refractory Membranoproliferative Glomerulonephritis
Seetha Radhakrishnan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Genome-wide association study identifies susceptibility loci for IgA nephropathy
Ali G. Gharavi et al.
NATURE GENETICS (2011)
Association of Genetic Variants in Complement Factor H and Factor H-Related Genes with Systemic Lupus Erythematosus Susceptibility
Jian Zhao et al.
PLOS GENETICS (2011)
Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis
Daniel P. Gale et al.
LANCET (2010)
A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration
Anne E. Hughes et al.
NATURE GENETICS (2006)
Share Paper
